How much Medicare stands to pay for FDA breakthrough devices
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
NRx submits 70,000-patient ketamine data to US FDA
NRx Pharmaceuticals (Nasdaq: NRXP) will submit real-world evidence from over 70,000 patients treated with intravenous ketamine…
Pulse oximeter study doesn’t settle issue of accuracy on darker skin
Rather than provide clarity on how to reduce racial bias in pulse oximeter readings, a long-awaited study commissioned…
Recall of Dietary Supplements–‘Life-Threatening’ – Newsweek
The U.S. Food and Drug Administration (FDA) has announced several recalls of dietary supplements after its analysis and…
Hormone therapy for menopause is being overhyped — again
If you’re a woman of a certain age, your social media feed may be filled with claims that a…
Johnson & Johnson MedTech submits Ottava surgical robot to FDA
Johnson & Johnson MedTech (NYSE: JNJ) + announced today that it submitted its Ottava surgical robotic system to…
US FDA to limit regulation of health and fitness wearables, commissioner says
By Puyaan Singh Jan 6 (Reuters) – The U.S. Food and Drug Administration said on Tuesday that it…
FDA relaxes oversight of AI-enabled devices and wearables
Food and Drug Administration Commissioner Marty Makary.ANDREW CABALLERO-REYNOLDS/AFP via Getty Images Lizzy Lawrence leads STAT’s coverage of the…
Tylenol, Advil, Purina, Haribo face urgent FDA recall
While a car recall is one notice I never ignore, I can’t ever remember throwing out a single…
Novo Nordisk just pulled off something nobody saw coming
Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry…
FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…